Does Wegovy Start Working Straight Away?

Wegovy (semaglutide) activates GLP-1 receptors involved in appetite regulation from the first dose, but appetite suppression grows gradually as the dose is titrated upward over roughly 16 weeks.
Measurable weight loss typically becomes consistent once you reach or approach the maintenance dose — not during the starter phase.
In the STEP 1 clinical trial (68 weeks, 2.4 mg semaglutide), participants lost an average of around 15% of body weight, a result that accumulated steadily over many months, not weeks.
Wegovy is a prescription-only medicine; a prescriber assesses suitability, sets your titration schedule and monitors your progress throughout.

Wegovy does not produce noticeable weight loss straight away. Most people begin their first 0.25 mg dose and feel little change for several weeks — that is completely expected. The medicine is working at a hormonal level from the first injection, but visible results take time to build. Here is what actually happens, and when.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What is really happening in the first weeks, and when does it build?

The myth: if you feel fine after week one, it is not working

The most common misunderstanding about Wegovy is that silence equals failure. People start the 0.25 mg dose, notice they are not dramatically less hungry, and wonder whether something has gone wrong. Nothing has gone wrong. The starting dose is not designed to produce significant appetite suppression, its job is to let your digestive system adjust to semaglutide before the dose climbs. Most of the gastrointestinal side effects people worry about (nausea, loose stools, indigestion) are related to dose level; beginning low reduces the chance of them hitting hard. So if week one feels almost ordinary, that is the point.

The titration schedule for Wegovy moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and up to 2.4 mg, each step held for roughly four weeks. The appetite-reducing effect deepens at each rung. If you are curious about whether Wegovy works straight away, the titration schedule helps explain why the process takes time rather than delivering immediate results. The process is running; the output takes time.

The NHS medicines page for semaglutide confirms that weight loss with Wegovy is gradual and is achieved alongside a reduced-calorie diet and increased physical activity, not separately from them.

When most people notice a real shift in hunger and weight

Appetite tends to change in a meaningful way once the dose reaches 1.0 mg or above, which for most people is around weeks nine to twelve of treatment. That is when the medicine is working at a level closer to its therapeutic effect. Some people notice hunger dropping sooner; others need the higher doses to feel much difference. Both are normal, individual response to GLP-1 medicines varies considerably.

Actual scale movement tends to lag behind the appetite shift by another few weeks, because weight loss requires a sustained calorie deficit to accumulate. If you are wondering when Wegovy starts working specifically for weight loss, the honest answer for most people is: meaningfully, from around months two to four, with the steepest progress typically between months four and twelve. The STEP 1 trial, published in the New England Journal of Medicine, tracked participants over 68 weeks, weight loss was not a sprint; it was a long, consistent arc.

One practical note on timing: if you are starting around a holiday, a busy travel period or a week when routine is disrupted, your prescriber can advise whether it is worth delaying. Consistency in eating habits, sleep and activity all support the medicine's effect, and understanding how to store Wegovy correctly is another practical step that helps maintain that consistency, so a stable fortnight at the start helps.

Side effects: when they appear and what they tell you

Paradoxically, some of the earliest signals that Wegovy is doing something are not weight-related at all, they are gastrointestinal. Nausea, a feeling of fullness after small meals, or mild reflux in the first days after a dose increase are common, especially as the schedule climbs. These typically ease within a week or two as the body adjusts. Many people ask whether Wegovy starts working right away, and these early gut signals are often the first indication that the medicine is interacting with receptors as intended, even before appetite or weight changes become obvious.

More serious symptoms require prompt attention. Severe stomach pain that spreads to the back, with or without vomiting, should be assessed urgently, the MHRA highlighted acute pancreatitis as a known, infrequent but serious risk for GLP-1 medicines in a Drug Safety Update published January 2026. Gallbladder symptoms, significant dehydration from persistent vomiting, or signs of an allergic reaction also warrant same-day medical contact. Any suspected side effects can be reported through the MHRA Yellow Card scheme.

The fuller picture of semaglutide's side-effect profile is covered in detail on our Wegovy information page, and a prescriber will walk through what to watch for before you start.

What affects how quickly Wegovy works for you specifically

Several factors shape how quickly and clearly someone responds. Dose level matters most, but so does consistency: Wegovy works best when taken on the same day each week, at the highest tolerated dose, alongside genuine changes to eating patterns and activity. Missing doses or frequently shifting your injection day slows the process.

Starting weight, metabolic factors and whether any weight-related conditions are present also influence the trajectory. A person with higher starting BMI may see a larger absolute reduction in kilograms early on while the percentage change builds steadily. There is no shortcut formula, which is exactly why the prescriber reviews progress before each dose increase rather than leaving titration to guesswork.

If you are weighing up which treatment approach suits your situation, or thinking about the private cost involved, our Wegovy pricing page sets out what is included in a legitimate private prescription. Treatment through a registered pharmacy requires a clinical assessment first, a prescriber at nume reviews every consultation personally before any medicine is dispensed. Whenever you are ready, you can speak to our prescribers to find out whether Wegovy is clinically suitable for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions